Summary
Signals through the CD95 surface receptor can specifically induce apoptosis. Some tumour cell lines are sensitive to CD95 signals, and insensitive cells can be converted to a sensitive phenotype if given appropriate treatment. To determine whether the apoptotic response of tumour cells to signalling through CD95 might be enhanced by ionizing irradiation, carcinoma cells were treated with either single-dose or fractionated γ-irradiation. The response to treatment with an agonist anti-CD95 antibody was enhanced by pretreatment with either a single large dose or daily fractionated radiation. Fractionated irradiation induced cumulative and prolonged up-regulation of CD95 expression in cell lines bearing functional p53. Since two of four cell lines exhibiting heightened responsiveness to CD95-mediated signals following fractionated irradiation express mutant p53 and displayed little or no up-regulation of CD95, enhanced responsiveness did not correlate with p53 status and CD95 up-regulation. Continuous inhibition of CD95/CD95–ligand interactions during fractionated irradiation provided no protective effect to cells, arguing that autologous CD95/CD95–ligand interactions did not contribute to the direct lethal effect of irradiation. We conclude that fractionated γ-irradiation provides an extended period of time when carcinoma cells are more responsive to CD95-mediated signals in vitro.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Ashkenas, J. & Werb, Z. (1996). Proteolysis and the biochemistry of life-or-death decisions. J Exp Med 183: 1947–1951.
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L. & Wyllie, A. H. (1993). Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849–852.
Dhein, J., Walczak, H., Baeumler, C., Debatin, K. M. & Krammer, P. H. (1995). Autocrine T-cell suicide mediated by APO-1 (Fas/CD95). Nature 373: 438–441.
Eischen, C. M., Schilling, J. D., Lynch, D. H., Krammer, P. H. & Leibson, P. J. (1996). Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J Immunol 156: 2693–2699.
Eischen, C. M., Kottke, T. J., Martins, L. M., Basi, G. S., Tung, J. S., Earnshaw, W. C., Leibson, P. J. & Kaufmann, S. H. (1997). Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood 90: 935–943.
Friesen, C., Herr, I., Krammer, P. H. & Debatin, K. M. (1996). Involvement of the CD95 (APO-1, Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 2: 574–577.
Fulda, S., Sieverts, H., Friesen, C., Herr, I. & Debatin, K. M. (1997). The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 57: 3823–3829.
Graham, M. L., Dalquist, K. E. & Horwitz, K. B. (1989). Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: analysis of breast cancer cell mixtures and genetic instability of the T47D line. Cancer Res 49: 3943–3949.
Haimovitz-Friedman, A., Kan, C. C., Ehleiter, D., Persaud, R. S., McLoughlin, M., Fuks, Z. & Kolesnick, R. N. (1994). Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 180: 525–535.
Herr, I., Wilhelm, D., Böhler, T., Angel, P. & Debatin, K. M. (1997). Activation of CD95 (APO- 1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J 16: 6200–6208.
Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J. L., Schroter, M., Burns, K., Mattmann, C., Rimoldi, D., French, L. E. & Tschopp, J. (1997). Inhibition of death receptor signals by cellular FLIP. Nature 388: 190–195.
Jäättelä, M., Benedict, M., Tewari, M., Shayman, J. A. & Dixit, V. M. (1995). Bcl-X and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 10: 2297–2305.
Krammer, P. H., Dhein, J., Walczak, H., Berhmann, I., Mariani, S., Matiba, B., Fath, M., Daniel, P. T., Knipping, E., Westendorp, M. O., Stricker, K., Bäumler, C., Hellbardt, S., Germer, M., Peter, M. E. & Debatin, K. M. (1994). The role of APO-1 mediated apoptosis in the immune system. Immunol Rev 142: 175–191.
Landowski, T. H., Gleason-Guzman, M. C. & Dalton, W. S. (1997a). Selection for drug resistance results in resistance to Fas-mediated apoptosis. Blood 89: 1854–1861.
Landowski, T. H., Qu, N., Buyuksal, I., Painter, J. S. & Dalton, W. S. (1997b). Mutations in the Fas antigen in patients with multiple myeloma. Blood 90: 4266–4270.
Lichter, A. S. & Lawrence, T. S. (1995). Recent advances in radiation oncology. N Engl J Med 332: 371–379.
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A. & Jacks, T. (1993). p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847–849.
Lu, X. & Lane, D. P. (1993). Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 75: 765–778.
Martinez-Lorenzo, M. J., Gamen, S., Etxeberria, J., Lasierra, P., Larrad, L., Pineiro, A., Anel, A., Naval, J. & Alava, M. A. (1998). Resistance to apoptosis correlates with a highly proliferative phenotype and loss of Fas and CPP32 (caspase-3) expression in human leukemia cells. Int J Cancer 75: 473–481.
Mori, S., Jewett, A., Murakami-Mori, K., Cavalcanti, M. & Bonavida, B. (1997). The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent. Cancer Immunol Immunother 44: 282–290.
Müller, M., Strand, S., Hug, H., Heinemann, E. M., Walczak, H., Hofmann, W. J., Stremmel, W., Krammer, P. H. & Galle, P. R. (1997). Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of p53. J Clin Invest 99: 403–413.
Nagata, S. (1997). Apoptosis by death factor. Cell 88: 355–365.
Oshimi, Y., Oda, S., Honda, Y., Nagata, S. & Miyazaki, S. (1996). Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J Immunol 157: 2909–2915.
Owen-Schaub, L. B., Zhang, W., Cusack, J. C., Angelo, L. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A. B., Zhang, W-W, Kruzel, E. & Radinsky, R. (1995). Wild-type human p53 and a temperature sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 15: 3032–3040.
Sheard, M. A., Vojtesek, B., Janakova, L., Kovarik, J. & Zaloudik, J. (1997). Up-regulation of Fas (CD95) in human p53wild-type cancer cells treated with ionizing radiation. Int J Cancer 73: 757–762.
Suda, T., Okazaki, T., Naito, Y., Yokota, T., Arai, N., Ozaki, S., Nakao, K. & Nagata, S. (1995). Expression of the Fas ligand in cells of T cell lineage. J Immunol 154: 3806–3813.
von Reyher, U., Sträter, J., Kittstein, W., Gschwendt, M., Krammer, P. H. & Möller, P. (1998). Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. Cancer Res 58: 526–534.
Williams, B. A., Makrigiannis, A. P., Blay, J. & Hoskin, D. W. (1997). Treatment of the P815 murine mastocytoma with cisplatin or etoposide up-regulates cell-surface Fas (CD95) expression and increases sensitivity to anti-Fas antibody-mediated cytotoxicity and to lysis by anti-CD3-activated killer-T cells. Int J Cancer 73: 416–423.
Zhan, Q., Fan, S., Bae, I., Guillouf, C., Liebermann, D. A., O’Connor, P. M. & Fornace, A. J. (1994). Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene 9: 3743–3751.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Sheard, M., Krammer, P. & Zaloudik, J. Fractionated γ-irradiation renders tumour cells more responsive to apoptotic signals through CD95. Br J Cancer 80, 1689–1696 (1999). https://doi.org/10.1038/sj.bjc.6690585
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690585
Keywords
This article is cited by
-
Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas
Bone Marrow Transplantation (2016)
-
The effect of cellular environment and p53 status on the mode of action of the platinum derivative LA-12
Investigational New Drugs (2010)
-
Post-irradiation hypoxic incubation of X-irradiated MOLT-4 cells reduces apoptotic cell death by changing the intracellular redox state and modulating SAPK/JNK pathways
Apoptosis (2005)
-
Low p21Waf1/Cip1 protein level sensitizes testicular germ cell tumor cells to Fas-mediated apoptosis
Oncogene (2004)
-
Simian virus-40 infection inhibits DNA damage-induced enhancement of CD95 expression and function
Oncogene (2002)